Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique

被引：7

作者：

Bastard, Mathieu ^{[1
]}

Molfino, Lucas ^{[2
]}

Mutaquiha, Claudia ^{[3
]}

Galindo, Miriam Arago ^{[2
]}

Zindoga, Pereira ^{[3
]}

Vaz, Deise ^{[2
]}

Mahinca, Ivan ^{[3
]}

DuCros, Philipp ^{[4
]}

Rusch, Barbara ^{[5
]}

Telnov, Alex ^{[5
]}

机构：

[1] Epictr, 8 Rue St Sabin, F-75011 Paris, France

[2] Med Sans Frontieres, Maputo, Mozambique

[3] Minis Hlth, Maputo, Mozambique

[4] Burnet Inst, Melbourne, Australia

[5] Med Sans Frontieres, Geneva, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2019年 / 69卷 / 10期

关键词：

multidrug-resistant tuberculosis; short regimen; bedaquiline; treatment outcomes; injectable drugs;

D O I：

10.1093/cid/ciz196

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.

引用

页码：1809 / 1811

页数：3

共 50 条

[41] Treatment of multidrug-resistant tuberculosis in Taiwan
Suo, J
Yu, MC
Lee, CN
Chiang, CY
Lin, TP
CHEMOTHERAPY, 1996, 42 : 20 - 23
[42] Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India
Singla, R.
Caminero, J. A.
Jaiswal, A.
Singla, N.
Gupta, S.
Bali, R. K.
Behera, D.
EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (04) : 956 - 962
[43] Diagnosis and treatment of multidrug-resistant tuberculosis
Kang, Young Ae
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2014, 57 (01): : 27 - 33
[44] Treatment of multidrug-resistant tuberculosis in China
Zhang, LX
CHEMOTHERAPY, 1996, 42 : 16 - 19
[45] Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia
Alene, Kefyalew Addis
Viney, Kerri
McBryde, Emma S.
Tsegaye, Adino Tesfahun
Clements, Archie C. A.
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 (03) : 351 - 362
[46] Treatment Outcomes of FluoroquinoloneResistant Multidrug-Resistant Tuberculosis: An Implication for Delamanid
Putra, Oki Nugraha
Purnamasari, Telly
TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (02) : 206 - 208
[47] Treatment of multidrug-resistant tuberculosis in Indonesia
Hadiarto, M
Tjandra, YA
Hudoyo, A
CHEMOTHERAPY, 1996, 42 : 24 - 29
[48] Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt
Gadallah, Mohsen A.
Mokhtar, Alaa
Rady, Mervat
El-Moghazy, Essam
Fawzy, Magdy
Kandil, Sahar Khalil
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (11) : 997 - 1003
[49] Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
Putra, Oki Nugraha
Indah, Nur
Purnamasari, Telly
Larasanti, Adi
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2024, 13 (04) : 430 - 435
[50] Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis
Xu, Jian
Wang, Bin
Hu, Minghao
Huo, Fengmin
Guo, Shaochen
Jing, Wei
Nuermberger, Eric
Lu, Yu
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)

← 1 2 3 4 5 →